| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |